Langerin is expressed in LCs which are located in the
epidermis and in
vaginal and
oral mucosa. LCs are
immune cells closely related to
macrophages, but by their function, they are more like
conventional dendritic cells (cDCs). Langerin recognizes and binds carbohydrates, such as
mannose,
fucose and
N-acetylglucosamine. Thus, LCs may react against
pathogens such as
HIV-1,
Mycobacterium leprae and
Candida albicans. After pathogen binding to langerin, fate of the pathogens is not yet understood. It has been proposed that the pathogen is internalised into a cytoplasmatic organelle called
Birbeck granule. There, degradation and antigen processing for presentation to
T-cells take place. For instance, langerin binds
lipoarabinomannans of
mycobacteria and inside the Birbeck granules, it contributes to the binding of the antigen to
CD1a molecule. In
mice, langerin is involved in antigen binding to
MHC II glycoproteins and to
MHC I glycoproteins during
cross-presentation. It seems an intracellular
Src homology domain of langerin is important for the formation of Birbeck granules. These organelles contain
Rab11a which is a molecule participating in langerin recycling. Langerin has similar function and structure as a DCs surface protein
DC-SIGN (CD209). Both receptors bind similar antigens via the CRD, for instance Mycobacterium tuberculosis and HIV-1. However, whereas HIV-1 binding to langerin leads to the elimination of the virus, HIV-1 binding to DC-SIGN leads to infection of the
cell. == Clinical significance ==